Generics Makers Urge 3rd Circ. To Nix Price-Fixing Classes

By Matthew Perlman · October 16, 2025, 7:29 PM EDT

Actavis and Mylan have urged the Third Circuit to reverse the certification of two classes of buyers for a pair of medications in the sprawling multidistrict litigation over alleged price-fixing in...

To view the full article, register now.

Documents

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

2:16-md-02724

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016


Case Title

Ahold USA Inc, et al v. Wockhardt USA LLC, et al

Case Number

25-2219

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 08, 2025


Case Title

1199SEIU National Benefit Fund, et al v. Wockhardt USA LLC, et al

Case Number

25-2220

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 08, 2025


Case Title

Ahold USA Inc, et al v. Sandoz Inc, et al

Case Number

25-2221

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 08, 2025


Case Title

American Federation of State County and Municipal, et al v. Taro Pharmaceuticals USA Inc, et al

Case Number

25-2222

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 08, 2025